Iontophoresis system

Information

  • Patent Grant
  • 6760618
  • Patent Number
    6,760,618
  • Date Filed
    Monday, September 18, 2000
    24 years ago
  • Date Issued
    Tuesday, July 6, 2004
    20 years ago
Abstract
An iontophoresis system comprises a power supply apparatus having a chargeable battery, a positive output terminal, a negative output terminal and a positive charge terminal, and a preparation having input terminals connected to output terminals of the power supply apparatus. The negative output terminal of the power supply apparatus also serves as a negative charge terminal for charging the battery. During charging, the preparation is removed, and terminals of a charger are connected to terminals of the power supply apparatus, respectively. The power supply apparatus comprises a power supply monitoring portion which gives a warning when a battery voltage becomes a predetermined value or lower and a control portion for controlling a power supply state from the output terminal.
Description




BACKGROUND OF THE INVENTION




The present invention relates to an iontophoresis system applied percutaneously or trans-mucosally, and in particular to a portable iontophoresis system.




Iontophoresis is a percutaneous absorption-promoting system which employs electricity for external stimulation. Its principle is such that skin barrier permeability of drug molecules is promoted by movements of positively-charged molecules from an anode to a cathode and those of negatively-charged molecules from the cathode to the anode in an electric field mainly produced between the anode and the cathode by power supply [refer to Journal of Controlled Release, Vol. 18, pages 213 to 220, 1992; Advanced Drug Delivery Review, Vol. 9, page 119, 1992; and Pharmaceutical Research, Vol. 3, pages 318 to 326, 1986].




Thus, in iontophoresis, an anode and a cathode are provided in pair and a current is generated between the anode and cathode, thereby moving a drug. In recent years, a constant current unit is employed so that a current can be maintained at a predetermined value irrespective of an impedance difference due to individual difference. This constant current unit can keep a drug delivery rate constant irrespectively of impedance because the drug delivery rate correlates with a current quantity. A unit of such type is disclosed in Japanese Patent Laid-Open Publication No. 5-245214, for example. In addition, a unit for controlling a drug supply rate with a program as required is disclosed in Japanese Patent Laid-Open Publication No. 7-124265, for example.




In the meantime, in order to achieve a small iontophoresis system suitable to be portable, in particular, it is required to minimize the number of circuit parts of a power supply apparatus and miniaturize the unit. Among them, in particular, it is desired to reduce a battery incorporated in the power supply apparatus in size and in weight. When a small battery is employed, in general, frequent battery replacement is required because of its small battery capacity, which requires a user to do cumbersome operation of battery replacement, and thus, is not preferable. In addition, it is desirable that battery replacement can be avoided as far as possible from an economical aspect or an environmental aspect including disposal of used battery.




Further, another problem with a portable power supply apparatus includes circuit malfunction caused by faults of components. At the time of designing a circuit for the power supply apparatus, safety is taken into account to avoid such discrepancies that, a high output current exceeding a set level is generated or an output cannot be stopped completely when it must be stopped, even if the above malfunction occurs. For example, such a system is disclosed in National Publication of International Patent Application No. 8-505541.




However, when any of the parts constituting a power supply apparatus fails, influence on operation of the power supply apparatus greatly differs depending on which of these parts fails. When a power supply apparatus itself cannot identify a failure, a user may use the failed unit repeatedly until the failure is found. In order to overcome these problems, a large-scale circuit is generally required, which acts against reductions in size and weights of a power supply apparatus.




SUMMARY OF THE INVENTION




In view of the foregoing circumstance, an object of the present invention is to provide a small and light iontophoresis system with superior usability.




The present inventors made efforts earnestly to reduce an iontophoresis system in size and weight. As a result, they found out that if a small secondary battery is employed for a power supply and at least one of charge terminals for charging the battery is also used as an output terminal, a small and light-weight iontophoresis system with superior usability could be used, and accomplished the present invention.




An iontophoresis system according to the present invention comprises a power supply apparatus having a chargeable battery and a plurality of output terminals and a preparation which is connected to the output terminals of the power supply apparatus and which is adopted to administer a drug percutaneously or trans-mucosally, wherein at least one of the output terminals of the power supply apparatus is also used as a charge terminal for charging the battery. Here, a secondary lithium battery, for example, is employed as a chargeable battery.




An iontophoresis power supply apparatus according to the present invention comprises a chargeable battery, a plurality of output terminals for outputting electric energy from the battery, and a charge terminal for charging the battery, wherein at least one of the output terminals is also used as a charge terminal. In addition, the present iontophoresis power supply apparatus preferably comprises a power supply monitoring portion that monitors a battery voltage and gives warning when the battery voltage becomes a predetermined value or lower. Further, the present power supply apparatus preferably comprises a control portion for controlling power supply of electric energy outputted from the output terminals. The control portion is adopted to record a power supply state of electric energy or to externally incorporate a program for power supply control of electric energy.




An iontophoresis charger according to the present invention is adopted to charge a battery of the iontophoresis power supply apparatus. This charger comprises an operational check portion which performs operational check of the power supply apparatus based on an inputted power supply record of the electric energy outputted from the power supply apparatus. This charger can comprise a display portion for displaying a power supply record of the power supply apparatus. In addition, the charger may comprise a program storage portion that stores a program for power supply control of the power supply apparatus.











BRIEF DESCRIPTION OF THE DRAWINGS





FIG. 1

is a view showing one embodiment of an iontophoresis system according to the present invention;





FIG. 2

is a block diagram depicting an example of configuring a charger according to the present invention;





FIG. 3

is a view showing another embodiment of an iontophoresis system according to the present invention;





FIG. 4

is a block diagram depicting another example of configuring a charger according to the present invention;





FIG. 5

is a view showing another embodiment of an iontophoresis system according to the present invention;





FIG. 6

is a block diagram depicting another example of configuring a charger according to the present invention; and





FIG. 7

is a view showing another example of an iontophoresis system according to the present invention.











DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS




Hereinafter, embodiments of an iontophoresis system according to the present invention will be described in detail with reference to the accompanying drawings.





FIG. 1

is a view showing one embodiment of an iontophoresis system according to the present invention. In this system, an iontophoresis power supply apparatus


100


is connected to a preparation


200


during driving. During power charging, the preparation


200


is removed and a charger


300


is connected to the power supply apparatus


100


instead.




The power supply apparatus


100


in the illustrative embodiment comprises three terminals, i.e., a positive (anode side) output terminal


8


, a negative (cathode side) output terminal


9


also serving as a charger, and a positive charge terminal


10


. Here, the negative output terminal


9


also serving as a charger, functions as a negative output terminal during system driving, and functions as a negative charge terminal during charging. As illustrated, the positive output terminal


8


is connected to the anode side of a battery


1


via an output control portion


6


and a DC/DC converter


4


, and the negative output terminal


9


is connected to cathode side of the battery


1


. In addition, the positive charge terminal


10


is connected to the anode side of the battery


1


. The DC/DC converter


4


and output control portion


6


are controlled by a signal from a control portion


5


. The control portion


5


inputs signals from the power monitoring portion


2


and voltage regulator


3


as well as an output of the output control portion


6


.




Here, a coin-shaped secondary lithium battery, for example, is employed as the battery


1


without being limited thereto. The power supply monitoring portion


2


is composed of a voltage monitoring IC, for example. When a battery voltage is a predetermined value or lower, a signal for warning a lowered battery voltage is outputted to the control portion


5


. The voltage regulator


3


is composed of a three-terminal regulator for smoothing a battery voltage, for example, and for supplying a predetermined voltage to the control portion


5


. The DC/DC converter


4


comprises a switching regulator for increasing the voltage of the battery


1


to a predetermined output voltage by generation and/or accumulation of back electromotive force of a coil, for example. The control portion


5


is composed of a microcomputer, a memory or the like, and controls start/stop of this apparatus, output supply/interruption, and an output voltage/output current or the like. The output control portion


6


is an output control switch for supplying or interrupting an output from the DC/DC converter


4


to the output terminal in accordance with a control signal from the control portion


5


, and is composed of a transistor or the like.




The power supply state of electric energy outputted from the output control portion


6


is recorded in an internal memory by means of the control portion


5


. In addition, the control portion


5


can add communication features so that a power supply record can be transmitted to the charger


300


and a program for setting a power supply pattern can be received from the charger


300


.




A resistor


7


A is a pull-down resistor for fixing the positive output terminal


8


to a voltage that the control portion


5


recognizes as a voltage of a predetermined value or lower (hereinafter, referred to as “L” level) when an output of the power supply apparatus


100


is stopped, and is connected between the positive output terminal


8


and the negative output terminal


9


. When the charger


300


is connected to the power supply apparatus


100


, the positive output terminal


8


is set to a voltage that the control portion


5


recognizes as a voltage of a predetermined value or higher (hereinafter, referred to as an “H” level). Component parts such as hooks or magnets, which are used both for power conduction and fixing, are preferably employed for the positive output terminal


8


and the negative output terminal


9


. Component parts for the positive charge terminal


10


may have a structure with an exposed metal face.




The preparation


200


comprises a drug containing electrode portion connected to a positive input terminal


201


and an opposite electrode portion connected to a negative input terminal


202


. The preparation


200


of this type is described in Japanese Patent Laid-Open Publication No. 2-241464, for example. In addition, the charger


300


comprises positive and negative charge terminals


301


and


302


and a control terminal


303


.





FIG. 2

is a block diagram depicting an example of configuration of a charger


300


according to the present invention. As shown in the figure, the charger


300


comprises an AC/DC converter


310


in which a direct current output side is connected to the positive and negative charge terminals


301


and


302


, a power cable


311


and a plug


312


which are connected to an alternating current input side of the AC/DC converter


310


, an operational check portion


313


connected to the control terminal


303


, a display portion


314


; a program storage portion


315


; a processing portion


316


for performing processing of each of these portions, and a fixed resistance


317


connected to the side of the operational check portion


313


of the positive charge terminal


301


. The plug


312


can be connected to a 100V receptacle for home use, and the AC/DC converter


310


outputs a 3V direct current voltage, for example. The operational check portion


313


inputs a power supply record of the electric energy outputted from the power supply apparatus


100


via the control terminal


303


, and performs operational check of whether or not the power supply apparatus


100


operates normally based on this power supply record. The display portion


314


is composed of a liquid crystal display, for example, capable of displaying this power supply record. The program storage portion


315


stores a program for power supply control of the electric energy employed in the power supply apparatus


100


, and transmits a desired program via the control terminal


303


upon a request from the power supply apparatus


100


. These are executed by the processing portion


316


.




Now, a description will be given to means for charging in an interface between the power supply apparatus


100


and the charger


300


and for operational check of a circuit, by citing an example. During charging, the input terminals


201


and


202


of the preparation


200


are removed from the positive output terminal


8


and the negative output terminal


9


of the power supply apparatus


100


. Then, the charge terminals


301


and


302


and a control terminal


303


are connected respectively to the positive terminal


10


, the negative output terminal


9


, and the positive output terminal


8


of the power supply apparatus


100


. Power is charged to the battery


1


via the charge terminals


301


and


302


of the charger


300


.




If a voltage level at the positive output terminal


8


is at an “L” level prior to charging, the voltage is increased to an “H” level by charging with the charger


300


. The control portion


5


that has detected the “H” level outputs a control signal to the DC/DC converter


4


and the output control portion


6


, and activates the apparatus. The control portion


5


controls the voltage, current, ON/OFF switching or the like at each set value in accordance with a predetermined pattern or protocol. The charger


300


inputs an output from the power supply apparatus


100


or its record via the positive output terminal


8


and the control terminal


303


, and checks whether or not an output or power supply is correct at the operational check portion


313


. The operational check portion


313


displays a blue light when an output or power supply is correct or displays a red light if it is not correct by employing a light emitting diode (LED) or the like. In addition, this output or power supply record can be displayed on the display portion


314


composed of a liquid crystal display or the like, for example. When a power supply pattern employed in the power supply apparatus


100


is changed, an operator selects a desired power supply pattern of the program storage portion


315


by key input, for example, whereby a program of a desired power supply pattern is transmitted to the control portion


5


of the power supply apparatus


100


via the control terminal


303


.





FIG. 3

is a view showing another embodiment of an iontophoresis system according to the present invention. A power supply apparatus


130


according to this embodiment is composed of two terminals, i.e., a positive output terminal also serving as a charger


13


and a negative output terminal also serving as a charger


9


. Here, the positive output terminal also serving as a charger


13


and the negative output terminal also serving as a charger


9


function as output terminals, respectively, during system driving, and function as charge terminals during charging. In this figure, the same reference numerals shown in

FIG. 1

denote the same elements. In this embodiment, there are provided a resistor


11


A and a diode


12


A that are serial connected between the anode side of the battery


1


and the positive output terminal


13


. An advantage of this circuit is that only a resistor


11


A and a diode


12


A may be employed as additional charging parts, and that the positive charge terminal


10


shown in

FIG. 1

can be eliminated.





FIG. 4

is a block diagram depicting an example of configuration of a charger


330


according to the present invention, the charger being employed here. In such configuration, an impedance of an output signal of the charger


330


is adjusted, whereby operational check during charging can be made. That is, in

FIG. 4

, the positive charge terminal


301


is also used as the control terminal


303


, and these terminals are connected to each other in the charger


330


. In addition, a current supplied to the connection point is regulated by a fixed resistor


317


. In such circuit configuration, the operational check portion


313


controls a voltage of the positive charge terminal


301


as an N-ch open drain output, whereby a signal can be transmitted or received even during charging.





FIG. 5

is a view showing another embodiment of an iontophoresis system according to the present invention. A power supply apparatus


150


according to the present embodiment comprises four terminals, i.e., a positive output terminal


8


, a negative output terminal also serving as a charger


9


, a positive charge terminal


10


, and a test terminal


15


. Here, the negative output terminal also serving as a charger


9


functions as an output terminal during system driving, and functions as a negative charge terminal during charging. In this figure, the same reference numerals shown in

FIG. 1

denote the same elements. In this embodiment, an on/off switch


14


and the test terminal


15


are provided. The on/off switch


14


is provided to interrupt power supply from the battery


1


to each portion during charging. The on/off switch


14


may be an electric switch such as FET (field effect transistor) or may be a mechanical contact such that power continuity is interrupted when this apparatus is mounted on the charger.





FIG. 6

is a block diagram depicting an example of configuration of a charger


350


according to the present invention, the charger being employed here. During charging, when power supply from the battery


1


to each portion is interrupted by opening the on/off switch


14


of the power supply apparatus


150


, the test terminal


15


is interrupted from the battery


1


. Thus, the charger


350


can make operational check of the power supply monitoring portion


2


and the voltage regulator


3


. This operational check is made by employing the test terminal


15


in which an adjusted output voltage from the charger


350


is set to a power voltage of the power supply apparatus


150


. That is, in

FIG. 6

, an output from the operational check portion


313


is supplied to the power supply apparatus


150


via a power supply terminal


304


and a test terminal


15


. Information concerning an output signal of the power supply monitoring portion


2


when the supplied voltage is changed and an output voltage of the voltage regulator


3


is read by the operational check portion


313


via the control portion


5


, the output control portion


6


, the positive output terminal


8


, and the control terminal


303


, thereby making operational check.





FIG. 7

is a view showing another embodiment of an iontophoresis system according to the present invention. A power supply apparatus


170


according to this embodiment is composed of two terminals, i.e., a positive and negative output terminal also serving as a charger


17


and a positive and negative output terminal also serving as a charger


18


. Here, the positive and negative output terminal also serving as a charger


17


and a positive and negative output terminal also serving as a charger


18


function as output terminals, respectively, during system driving, and functions as charge terminals during charging. In this figure, the same reference numerals shown in

FIG. 1

denote the same elements. In this embodiment, there are provided a resistor


11


B and a diode


12


B which are connected in series between the anode side of the battery


1


and the positive and negative output terminal also serving as a charger


17


, a resistor


11


C and a diode


12


C which are connected in series between the anode side of the battery


1


and the positive and negative output terminal also serving as a charger


18


, a resistor


7


B and a diode


16


B which are connected in parallel between the cathode side of the battery


1


and the positive and negative output terminal also serving as a charger


17


, and a resistor


7


C and a diode


16


C which are connected in parallel between the cathode side of the battery


1


and the positive and negative output terminal also serving as a charger


18


, respectively.




In the embodiment shown in

FIG. 7

, a power supply apparatus


170


is employed as a positive and negative inverting type apparatus. During system driving, the output polarity can be arbitrarily changed by means of the positive and negative output terminals also serving as chargers


17


and


18


. In addition, during charging, when a charger


330


is connected to the positive and negative output terminals also serving as chargers


17


and


18


, one positive and negative charge terminal enters an “H” level, and the other enters an “L” level by way of an output signal from the charger


330


. Here, in the case where the positive and negative output terminal also serving as a charger


17


indicates the “H” level, the signal is inputted to the control circuit


5


in the same way as each portion, and similar operational check is made. In addition, by way of the “H” level signal, a closed circuit is formed by diodes


12


B and


16


C, and the battery


1


is charged. Further, in the case where the positive and negative output terminal also serving as a charger


18


indicates the “H” level, the closed circuit is formed by resister


11


C, diodes


12


C and


16


B, and the battery


1


is charged.




In this manner, in this embodiment, there is provided a circuit that serves as the positive and negative inverting type apparatus, thereby making it possible to perform charging on both sides. In the case where the power supply apparatus and the charger are mounted in a predetermined direction by mounting means, a closed circuit for charging may be formed in either one direction.




In addition, when battery charging is in progress, a pilot lamp of the power supply apparatus or the charger is lit or blinked, thereby making it possible to display the charging is in progress. Further, an arbitrary function can be added by providing a charger with key input for setting or changing a power supply program.




As described above, in this embodiment, a secondary battery that is a chargeable battery is employed as a battery


1


. Secondary batteries include, for example, a nickel-cadmium storage battery, a nickel-hydrogen storage battery, a lithium ion battery, a secondary lithium battery or the like. Here, the respective batteries are characterized as follows.




A nickel-cadmium storage battery is one of the currently most popular secondary batteries. A battery voltage is as low as about 1.2 V. Thus, as a power supply of the control portion composed of microcomputers or the like, it is required to increase pressure or to employ a plurality of batteries. In addition, this type of battery uses cadmium and thus, it has some problem in environmental adoption, though chargeable. However, the battery is characterized by comparatively modest price and high energy capacity. Thus, there is only a little need for paying attention to circuit power reduction, and there is such an advantage that a circuit can be easily configured.




Since a battery voltage of a nickel-hydrogen storage battery is about 1.2 V as low as the nickel-cadmium storage battery, it is required to increase pressure or to employ a plurality of batteries when used as a power supply of the control portion. However, this battery is free of cadmium, thereby making it possible to enhance environmental adoption, difficulty of which is a disadvantage of the nickel-cadmium storage battery. In addition, the battery is superior in that its rectangular shape increases storage efficiency.




A lithium ion battery is comparatively expensive, and the commercially available battery size is larger than the nickel-hydrogen storage battery size. Since its battery voltage is as high as about 3.6 V, a single battery can be employed as a power supply. In addition, this battery is superior in environmental adoption, is characterized by high energy capacity, and has the most excellent performance among from the current batteries.




Various secondary lithium batteries are available. Secondary batteries with about 3 V in battery voltage include a secondary manganese dioxide-lithium battery, a secondary vanadium-lithium battery or the like. Secondary batteries with about 1.5 V in battery voltage include a secondary vanadium-niobium-lithium battery or the like. These batteries are disadvantageous in high internal impedance or small energy capacity, and are small in size and light in weight in comparison with any other secondary battery. Among them, the secondary manganese dioxide-lithium battery and a secondary vanadium niobium lithium battery are preferably employed because the vanadium-lithium secondary battery has quite high internal impedance and low usability. In particular, there are most preferably employed a coin-shaped secondary manganese dioxide-lithium battery with 3 V in battery voltage (ML2016 and ML2032 available from Hitachi Maxel Co., Ltd. and ML1220, ML2016, and ML2430 available from Sanyo Denki Co., Ltd.).




An iontophoresis system according to the present invention is suitable to be portable. Its power supply apparatus is composed of small parts, and performs charging every time the apparatus used in predetermined number. Thus, a coin-shape secondary lithium battery with its low capacity is most preferably employed without being limited thereto.




In addition, in the case where the above secondary lithium battery is employed, a plurality of the batteries may be employed. In the case of a primary battery, it is desired to select a battery size capable of being driven by a single battery because of cumbersome battery replacement and economical aspect. In the case of a secondary battery, when one battery is employed and when two batteries are employed, if its energy capacity and voltage are the same, an optimal battery voltage in the circuit configuration can be selected. In addition, in its storage as well, optimal layout can be provided depending on a structure of the apparatus.




Drugs employed in the preparation


200


of an iontophoresis system according to the present invention are exemplified below.




As an antibiotic, gentamicin sulfate, sisomicin sulfate, tetracycline hydrochloride, ampicillin, cefalotin sodium, cefotiam hydrochloride, cefazolin sodium or the like may be used.




An anti-fungal agent, amorolfine hydrochloride, croconazole hydrochloride or the like may be used. As an anti-lipemic agent, atorvastatin, cerivastatin, pravastatin sodium, simvastatine or the like may be used.




As an agent for the circularatory systems, delapril hydrochloride or the like may be used. As an anti-platelet drug, ticlopidine hydrochloride, cilostazol, aspirin or the like may be used.




As an anti-tumor agent, bleomycin hydrochloride, actinomycin D, mitomycin C, fluorouracil or the like may be used.




As antipyretic, analgesic, and antiphlogistic, ketoprofen, flurbiprofen, felbinac, indometacin sodium, diclofenac sodium, loxoprofen sodium, buprenorphin hydrochloride, eptazocine hydrobromide, pentazocine, butorphanol tartrate, tramadol hydrochloride, morphine hydrochloride, morphine sulfate, fentanyl citrate, fentanyl or the like may be used.




An anti-tussive and expectorant agent, ephedrine hydrochloride, codeine phosphate or the like may be used. As a sedation agent, chlorpromazine hydrochloride, atropine sulfate or the like may be used.




As a muscle relaxant, lanperisone hydrochloride, eperisone hydrochloride, tubocurarine chloride, lanpesorine hydrochloride, eperisone hydrochloride or the like may be used. As an anti-epileptic agent, clonazepam, zonisamide, sodium phenytoin, ethosuximide or the like may be used.




As an anti-ulcer agent, metoclopramide or the like may be used. As an antidepressant, trazodone hydrochloride, imipramine hydrochloride or the like may be used.




As an anti-allergic agent, cetirizine hydrochloride, olopatadine hydrochloride, ketotifen fumarate, azelastine hydrochloride or the like may be used. As an arrhythmic treatment agent, diltiazem hydrochloride, propranolol hydrochloride or the like may be used.




As a vasodilatory agent, tolazoline hydrochloride or the like may be used. As an anti-hypertensive diuretic, metolazone or the like may be used.




As a diabetes treatment agent, pioglitazone hydro-chloride, mexiletine hydrochloride, glibenclamide, metoformin hydrochloride or the like may be used.




As an anti-coagulant, sodium citrate or the like may be used. An a styptic, employed menatetrenone, tranexamic acid or the like may be used.




As an anti-tuberculosis agent, isoniazid, ethambutol hydrochloride or the like may be used. As a hormone agent, estradiol, testosterone, prednisolone acetate, dexamethasone sodium phosphate or the like may be used.




As an opioid antagonist agent, levallorphan tartrate, naloxone hydrochloride or the like may be used.




As described above, in an iontophoresis system according to the present invention, the conventional problems such as those concerning battery replacement and disposal caused when a primary battery is employed as a battery of a power supply apparatus are dissolved by employing a secondary battery. In addition, at least one of the charge terminals for charging a battery, which is indispensable, also serves as an output terminal, thereby providing excellent economical aspect, environment adoption, compactness, usability or the like.




In the case of a primary battery, a battery with a high capacity must be employed so that the battery can be repeatedly used to minimize battery replacement and disposal. In the case of a charge type battery, a battery with a low capacity is provided such that one power supply quantity is satisfied, thereby making it possible to ensure miniaturization. Such power supply apparatus of a small size and a light weight is preferably used for a self-adhesive type iontophoresis system in which a power supply apparatus and a preparation are adhered to a living body by adhesiveness of the preparation containing a drug or electrolyte, and is particularly preferable in application over a long period of time. This is because the present invention can reduce discomfort with a user at a projection of the conventional power supply apparatus or peeling a preparation off a living body due to the weight of the power supply apparatus.




Further, a variety of features such as fail safe function is provided in an interface with an accompanying charger, whereby high safety can be provided in spite of a small sized power supply apparatus.




Heretobefore, embodiments of the present invention have been described with reference to the accompanying drawings. The present invention is not limited to these embodiments, and various modifications can occur by one skilled in the art.




According to the present invention, an iontophoresis system with a small size, light weight, and excellent usability can be provided.



Claims
  • 1. An iontophoresis system comprising:a power supply apparatus having a chargeable battery and a plurality of output terminals for outputting electric energy from said battery in accordance with a predetermined pattern or protocol; and a preparation which administers a drug percutaneously or transmucosally, being connected to the output terminals of said power supply apparatus, wherein during power charging, said preparation is removed, and at least one of the output terminals of said power supply apparatus also serves as a charge terminal for charging said battery.
  • 2. The iontophoresis system according to claim 1, wherein said battery is a secondary lithium battery.
  • 3. An iontophoresis power supply apparatus comprising a chargeable battery, a plurality of output terminals for outputting electric energy from said battery in accordance with a predetermined pattern or protocol, and a charge terminal for charging said battery, wherein during power charging, said preparation is removed, and at least one of said output terminals also serves as said charge terminal.
  • 4. The iontophoresis power supply apparatus according to claim 3, further comprising a power supply monitoring portion monitoring a voltage of said battery and giving a warning when said battery voltage becomes a predetermined value or lower.
Priority Claims (1)
Number Date Country Kind
11-265251 Sep 1999 JP
US Referenced Citations (5)
Number Name Date Kind
5688232 Flower Nov 1997 A
5764034 Bowman Jun 1998 A
5834921 Mercke et al. Nov 1998 A
6154012 Drori Nov 2000 A
6208891 Flower Mar 2001 B1